BioCatalystWatch
AEONWorkspace / AEON / OverviewCompany library
AEON Biopharma, Inc. logo

AEON Biopharma, Inc.

AEON Biopharma, Inc. (AEON)

Website

Price
Market cap
Next catalystCMAP study initiation in Q1 2027, subject to additional funding and applicable regulatory requirementsABP-450 — comparative CMAP pharmacodynamic study · Trial initiationSEC filing ↗
Cash

Chart & Events

Candle interval

Core Clinical

ABP-450

SNAP-25

Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

ABP-450

SNAP-25

Upcoming / outlook

Other pipelines

Approved / commercial

Approved

PreINDP1P2P3FilingApproved

History / paused

ABP-450

SNAP-25

PreINDP1P2P3FilingApproved
ABP-450

SNAP-25

PreINDP1P2P3FilingApproved

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Company funding outlook

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

AEON PR & News

PR & News

AEON SEC archive